Key result
Trans-jugular transcutaneous closure of ASD with an adjustable curved sheath under echocardiography guidance resulted in 0% complications and a 1.9% residual shunt rate that self-closed.
Why the study?
Traditional transcatheter ASD closure via the femoral vein carries radiation damage risks, prompting interest in echocardiography-guided transcutaneous trans-jugular closure using an adjustable curved sheath.
Does trans-jugular transcutaneous closure of ASD with an adjustable curved sheath under echocardiography guidance provide safe and effective outcomes in patients with ASD?
Observational (n=156)
No
Does trans-jugular transcutaneous closure of ASD with an adjustable curved sheath under echocardiography guidance provide safe and effective outcomes in patients with ASD?
Trans-jugular transcutaneous closure of ASD using an adjustable curved sheath under echocardiography guidance is a safe, effective, and radiation-free alternative, particularly suitable for pediatric patients.
May support radiation-free trans-jugular ASD closure in select cases; leaves open prospective trials versus femoral access.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) conducted an observational in Atrial septal defect (n=156). Trans-jugular transcutaneous closure of ASD with an adjustable curved sheath under echocardiography guidance was evaluated on Complications (atrioventricular block, reoperation, pericardial effusion). Trans-jugular transcutaneous closure of ASD with an adjustable curved sheath under echocardiography guidance resulted in 0% complications and a 1.9% residual shunt rate that self-closed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: